THE Federal Government has confirmed the Community Pharmacy in Health Care Homes Trial will end on 30 Jun.
The Sixth Community Pharmacy Agreement-funded program was part of a package of measures to support new and expanded pharmacy programs including the incorporation of medication management programs within health care homes.
A Pharmacy Guild of Australia spokesperson noted the Health Care Homes model was designed to help Australians better manage their conditions by giving them access to coordinated, integrated care, tailored to their needs.
"Through the community pharmacy trial patients have benefited from patient-centred, coordinated medication management services delivered by their community pharmacy of choice in conjunction with their Health Care Home," the spokesperson said.
"The Guild thanks all community pharmacies that have participated in this significant trial with the goal of improving the health outcomes of people with complex and chronic conditions in Australia."
Outcomes of the trial will be evaluated by the Department of Health, and a final report will be published on the Department's website.
If your pharmacy has registered or provided services for this trial you will receive email correspondence from the Pharmacy Guild advising you of next steps.
Under the terms of the 6CPA program, all trial services must be completed in GuildCare software by 30 Jun in order to be paid.
For help with recording your Health Care Homes services, please call GuildLink on 1300 647 492 or email support@guildcare.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 May 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 May 21
